Roche's Genen­tech touts la­bel ex­pan­sion for block­buster lung can­cer drug Ale­cen­sa

Roche’s Genen­tech said that Ale­cen­sa scored a la­bel ex­pan­sion from the FDA, with the drug now ap­proved as an ad­ju­vant treat­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.